top of page
Biotech Stories, News & Events

Similar Stories from FIB

Member Introduction: Bonalive – Bioactive Technology as a Sustainable Treatment Against Antibiotic Resistance
24/03/25
Member Introduction: Bonalive – Bioactive Technology as a Sustainable Treatment Against Antibiotic Resistance
Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio
20/03/25
Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio
Member Introduction: StemSight - A New Treatment for Corneal Blindness 
10/03/25
Member Introduction: StemSight - A New Treatment for Corneal Blindness 
Made by Cells - Biotech Forum - April 10th 2025
24/02/25
Made by Cells - Biotech Forum - April 10th 2025

Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!

Synbio Powerlabs is currently building a state-of-the-art pilot facility in Lappeenranta, Finland. Upon completion, this facility will feature aseptic, food-grade bioreactors ranging from 50 liters to 2 x 27,000 liters, with intermediate capacities of 500 liters and 10,000 liters. This infrastructure will provide crucial opportunities for companies worldwide to scale up their groundbreaking biotech innovations.


Their recent collaboration with Ivy Farm, a British company, exemplifies their commitment to pushing the boundaries of biomanufacturing. This partnership aims to scale up cultivated meat production to a significant 10,000 liters.


For more information about Synbio Powerlabs, please visit their website at www.synbiopowerlabs.com.




bottom of page